Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target?
- PMID: 29679095
- PMCID: PMC5986855
- DOI: 10.1007/s00018-018-2811-2
Implication of the VRK1 chromatin kinase in the signaling responses to DNA damage: a therapeutic target?
Abstract
DNA damage causes a local distortion of chromatin that triggers the sequential processes that participate in specific DNA repair mechanisms. This initiation of the repair response requires the involvement of a protein whose activity can be regulated by histones. Kinases are candidates to regulate and coordinate the connection between a locally altered chromatin and the response initiating signals that lead to identification of the type of lesion and the sequential steps required in specific DNA damage responses (DDR). This initiating kinase must be located in chromatin, and be activated independently of the type of DNA damage. We review the contribution of the Ser-Thr vaccinia-related kinase 1 (VRK1) chromatin kinase as a new player in the signaling of DNA damage responses, at chromatin and cellular levels, and its potential as a new therapeutic target in oncology. VRK1 is involved in the regulation of histone modifications, such as histone phosphorylation and acetylation, and in the formation of γH2AX, NBS1 and 53BP1 foci induced in DDR. Induction of DNA damage by chemotherapy or radiation is a mainstay of cancer treatment. Therefore, novel treatments can be targeted to proteins implicated in the regulation of DDR, rather than by directly causing DNA damage.
Keywords: 53BP1; DNA damage response; H2AX; Ionizing radiation; NBS1; Phosphorylation; VRK1; p53.
Conflict of interest statement
The authors declare no conflict of interests.
Figures



Similar articles
-
Olaparib and ionizing radiation trigger a cooperative DNA-damage repair response that is impaired by depletion of the VRK1 chromatin kinase.J Exp Clin Cancer Res. 2019 May 17;38(1):203. doi: 10.1186/s13046-019-1204-1. J Exp Clin Cancer Res. 2019. PMID: 31101118 Free PMC article.
-
VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage.Epigenetics. 2015;10(5):373-83. doi: 10.1080/15592294.2015.1028708. Epub 2015 Apr 29. Epigenetics. 2015. PMID: 25923214 Free PMC article.
-
The human VRK1 chromatin kinase in cancer biology.Cancer Lett. 2021 Apr 10;503:117-128. doi: 10.1016/j.canlet.2020.12.032. Epub 2021 Jan 29. Cancer Lett. 2021. PMID: 33516791 Review.
-
VRK1 phosphorylates and protects NBS1 from ubiquitination and proteasomal degradation in response to DNA damage.Biochim Biophys Acta. 2016 Apr;1863(4):760-9. doi: 10.1016/j.bbamcr.2016.02.005. Epub 2016 Feb 9. Biochim Biophys Acta. 2016. PMID: 26869104
-
An insight into understanding the coupling between homologous recombination mediated DNA repair and chromatin remodeling mechanisms in plant genome: an update.Cell Cycle. 2021 Sep;20(18):1760-1784. doi: 10.1080/15384101.2021.1966584. Epub 2021 Aug 26. Cell Cycle. 2021. PMID: 34437813 Free PMC article. Review.
Cited by
-
Traditional Herbal Medicine: A Potential Therapeutic Approach for Adjuvant Treatment of Non-small Cell Lung Cancer in the Future.Integr Cancer Ther. 2022 Jan-Dec;21:15347354221144312. doi: 10.1177/15347354221144312. Integr Cancer Ther. 2022. PMID: 36567455 Free PMC article. Review.
-
VRK1 Depletion Facilitates the Synthetic Lethality of Temozolomide and Olaparib in Glioblastoma Cells.Front Cell Dev Biol. 2021 Jun 14;9:683038. doi: 10.3389/fcell.2021.683038. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34195200 Free PMC article.
-
Barrier-to-autointegration factor: a first responder for repair of nuclear ruptures.Cell Cycle. 2021 Apr;20(7):647-660. doi: 10.1080/15384101.2021.1892320. Epub 2021 Mar 8. Cell Cycle. 2021. PMID: 33678126 Free PMC article. Review.
-
Olaparib and ionizing radiation trigger a cooperative DNA-damage repair response that is impaired by depletion of the VRK1 chromatin kinase.J Exp Clin Cancer Res. 2019 May 17;38(1):203. doi: 10.1186/s13046-019-1204-1. J Exp Clin Cancer Res. 2019. PMID: 31101118 Free PMC article.
-
The Vaccinia Virus B12 Pseudokinase Represses Viral Replication via Interaction with the Cellular Kinase VRK1 and Activation of the Antiviral Effector BAF.J Virol. 2021 Jan 13;95(3):e02114-20. doi: 10.1128/JVI.02114-20. Print 2021 Jan 13. J Virol. 2021. PMID: 33177193 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous